Apollo VCT portfolio company story: Flexzo
Flexzo uses AI to help NHS Trusts and healthcare organisations fill staffing gaps, reduce agency reliance and streamline workforce management.
What Flexzo does
Developed by HealsGood, Flexzo is an AI-powered workforce platform designed to help healthcare organisations manage staffing more efficiently. Healthcare providers often need to fill staffing gaps quickly while ensuring clinicians have the right skills, availability and compliance requirements, a process that can involve multiple systems and significant administration.
Flexzo uses AI to match healthcare professionals with suitable shifts based on factors such as availability and location. The platform also supports compliance checks and workforce planning, helping organisations manage internal and shared staff banks more effectively.
By reducing reliance on manual processes and external staffing agencies, Flexzo aims to simplify workforce management, improve efficiency and help healthcare providers manage costs.
Why we like it
We like Flexzo because it is addressing a significant challenge facing healthcare organisations, which continue to experience workforce shortages and cost pressures while seeking ways to improve staffing efficiency and reduce reliance on agencies. The platform combines AI-powered matching with healthcare-specific staffing and compliance workflows, helping to automate the process of identifying and filling workforce gaps rather than simply digitising recruitment. We also value the team’s direct experience in healthcare staffing, which has enabled them to build a solution around the practical needs and day-to-day workflows of healthcare providers, combining deep sector expertise with innovative technology.
Key risks to remember
Please remember that the value of an investment in Octopus Apollo VCT, and any income from it, can fall as well as rise. Investors may not get back the full amount they invest.
Tax treatment depends on individual circumstances and may change in the future. Tax reliefs depend on the VCT maintaining its qualifying status.
VCT shares could fall or rise in value more than shares listed on the main market of the London Stock Exchange. They may also be harder to sell.
Investors should only subscribe for shares on the basis of information contained in the prospectus, supplementary prospectus, AIFMD supplement and the Key Information Document (KID) available on the Apollo VCT product page.
More companies we’ve backed
The Safeguarding Company
Providing safeguarding software to schools and organisations in the UK and internationally.
Sova
Helps companies improve transparency and diversity in their hiring processes.
Tendable
Digital quality inspection platform designed to support the health and social sectors.
We’re here to support you
Got a question?